oravax
said
thursday
institute
reorganization
plan
designed
reduce
operating
expenses.the
company
said
wants
cut
20
positions
leaving
65
time
employees.the
company
said
currently
seeking
corporate
partner
facilitate
commercial
development
europe
certain
products.oravax
biopharmaceutical
company
engaged
discovery
development
oral
vaccines
noninjected
antibody
products
prevent
treat
diseases
infect
human
body
mucosal
linings
